LFVN Lifevantage PE ratio, current and historical analysis
- Stocks
- Consumer Defensive
- NASDAQ: LFVN
- PE Ratio
The PE ratio for Lifevantage stock stands at 16.36 as of May 9, 2025. The calculation is based on the latest EPS of $0.75 and the stock price of $12.27 per share. A decrease of 41% has been observed in the PE ratio compared to its average of 27.7 of the past four quarters.
LFVN PE ratio history
Over the last ten years, the average PE ratio of Lifevantage has been 23.93. The current 16.36 price-to-earnings ratio is 32% less than the historical average. Analyzing the last ten years, LFVN's PE ratio reached its highest point in the Sep 2022 quarter at 75, with a price of $3.75 and an EPS of $0.05. The Mar 2022 quarter saw the lowest point at 6.7, with a price of $4.76 and an EPS of $0.71.
Lifevantage PE ratio by year
Maximum annual increase: 325.17% in 2016
Maximum annual decrease: -59.44% in 2014
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 26.75 | 22.99% | $6.42 | $0.24 |
| 2023 | 21.75 | 19.97% | $4.35 | $0.2 |
| 2022 | 18.13 | 126.91% | $4.35 | $0.24 |
| 2021 | 7.99 | -51.55% | $7.35 | $0.92 |
| 2020 | 16.49 | -32.67% | $13.52 | $0.82 |
| 2019 | 24.49 | 57.59% | $12.98 | $0.53 |
| 2018 | 15.54 | -56.93% | $6.37 | $0.41 |
| 2017 | 36.08 | 16.73% | $4.33 | $0.12 |
| 2016 | 30.91 | 325.17% | $13.6 | $0.44 |
| 2015 | 7.27 | -45.91% | $3.71 | $0.51 |
| 2014 | 13.44 | -59.44% | $10.08 | $0.75 |
| 2013 | 33.14 | 40.54% | $16.24 | $0.49 |
| 2012 | 23.58 | N/A | $19.81 | $0.84 |
| 2011 | N/A | N/A | $10.5 | -$4.83 |
| 2010 | N/A | N/A | $3.57 | -$1.33 |
Lifevantage PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 19.44 | -33.47% | $14.58 | $0.75 |
| Dec 2024 | 29.22 | -17.76% | $17.53 | $0.6 |
| Sep 2024 | 35.53 | 32.82% | $12.08 | $0.34 |
| Jun 2024 | 26.75 | 23.79% | $6.42 | $0.24 |
| Mar 2024 | 21.61 | -17.17% | $6.05 | $0.28 |
| Dec 2023 | 26.09 | -19.1% | $6 | $0.23 |
| Sep 2023 | 32.25 | 48.28% | $6.45 | $0.2 |
| Jun 2023 | 21.75 | N/A | $4.35 | $0.2 |
| Mar 2023 | N/A | N/A | $3.59 | -$0.05 |
| Dec 2022 | N/A | N/A | $3.72 | -$0.04 |
| Sep 2022 | 75 | 313.68% | $3.75 | $0.05 |
| Jun 2022 | 18.13 | 170.6% | $4.35 | $0.24 |
| Mar 2022 | 6.7 | -21.55% | $4.76 | $0.71 |
| Dec 2021 | 8.54 | 26.14% | $6.32 | $0.74 |
| Sep 2021 | 6.77 | -15.27% | $6.77 | $1 |
LFVN average PE ratio chart
Currently, LFVN's PE ratio is under its 3, 5 and 10-year averages.
LFVN PE vs peers
LFVN's PE ratio is less than its peer stock NATR, but it is above USNA's and MTEX's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MTEX Mannatech Inc | 8.37 | $21.01M |
| USNA Usana Health Sciences Inc | 16.12 | $549.38M |
| LFVN Lifevantage Corp | 16.36 | $154.46M |
| NATR Natures Sunshine Products Inc | 25.09 | $253.24M |
| OGEN Oragenics Inc | N/A | $3.62M |
Frequently asked questions
What is Lifevantage's PE ratio?
As of May 9, 2025, LFVN stock has a price to earnings ratio of 16.36.
What is the 3-year average PE ratio for Lifevantage (LFVN)?
As an average over the last 3 years, LFVN stock has a PE ratio of 30.58.
What is the 5-year average PE ratio for Lifevantage (LFVN)?
As an average over the last 5 years, LFVN stock has a PE ratio of 21.59.
What is the highest PE ratio for LFVN?
Over the last ten years, the quarterly PE ratio reached its highest level at 75 in the Sep 2022 quarter.
How does the current PE ratio for LFVN compare to its historical average?
LFVN's current price to earnings ratio is 32% below its 10-year historical average.
How is LFVN's PE ratio calculated (Lifevantage PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (May 9, 2025), Lifevantage's share price is $12.27. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.75. Therefore, Lifevantage's price to earnings ratio for today is 16.36. PE RATIO(16.36) = STOCK PRICE($12.27) / TTM EPS($0.75)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.